Home All news

Cardiff Triathlon and Velindre Cancer Centre team up for fourth year

Cardiff Triathlon finish line

Always Aim High Events and Velindre Cancer Centre have announced a continuation of their partnership, which sees Velindre become the official charity partner of the Cardiff Triathlon for a fourth year.

Always Aim High Events notes that the partnership between the Cardiff Triathlon and Velindre has ‘gone from strength to strength since the first race in 2015, with all signs pointing to a record breaking year in 2018.’

Michael Locke, Fundraiser at Velindre said “Since our charitable partnership started in 2015, the Cardiff Triathlon has generated over £30,000 for cancer patients at Velindre. We are extremely grateful to now be chosen as the official charity for the fourth consecutive year and look forward to our incredible supporters taking part in this wonderfully organized event again.”

Tim Lloyd, Director at Always Aim High Events, organiser of the Cardiff Triathlon, said ”We are so happy to continue our support of Velindre at the Cardiff Triathlon 2018. The work that is done at Velindre is incredible and has touched so many people on a personal level. It is an absolute pleasure to be able to feed something back in the way that we do.”

He continued, “Exciting news around the Cardiff Triathlon will be announced shortly and we hope that more and more triathletes will get involved in this amazing capital city event and support the wonderful Velindre fundraising team.”

The 2018 edition of the Cardiff Triathlon promises to the biggest yet. As well as the Super Sprint, Sprint and Olympic distance races, the triathlon has also been granted ITU Sprint Age Group Qualifier 2018-2019 status, bringing a whole new element of draft legal action to the weekend.

Velindre is Wales’ premier Cancer Centre, providing care, support and treatment to cancer patients and their families for over 60 years. Velindre is the major provider of radiotherapy and other specialised anti-cancer treatments in Wales. The organisation notes that access to radiotherapy is critical to improving patient outcomes for cancer.




Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.